George W. Buchman
Corporate Officer/Principal bij Catalent Maryland, Inc.
Profiel
George W.
Buchman is currently the VP-Preclinical Services & Process Development at Catalent Maryland, Inc. Previously, he worked as the Chief Scientific Officer & Vice President at Chesapeake PERL, Inc. He obtained his undergraduate degree from Albright College and the University of Maryland.
Actieve functies van George W. Buchman
Bedrijven | Functie | Begin |
---|---|---|
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | 01-01-2014 |
Eerdere bekende functies van George W. Buchman
Bedrijven | Functie | Einde |
---|---|---|
Chesapeake PERL, Inc.
Chesapeake PERL, Inc. BiotechnologyHealth Technology Chesapeake PERL, Inc. operates as a biotechnology company which develops and produces proteins. Its proprietary technology - PERLXPRess, which uses insect larvae allows manufacturing without expensive process development for scale-up. The firm also produces humanized glycoproteins and human therapeutics, including kinases, viral antigens and antibodies. The company was founded by Terry E. Chase, Minh Q. Pham and William E. Bentley in 1998 and is headquartered in Savage, MD. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van George W. Buchman
Albright College | Undergraduate Degree |
University of Maryland | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Chesapeake PERL, Inc.
Chesapeake PERL, Inc. BiotechnologyHealth Technology Chesapeake PERL, Inc. operates as a biotechnology company which develops and produces proteins. Its proprietary technology - PERLXPRess, which uses insect larvae allows manufacturing without expensive process development for scale-up. The firm also produces humanized glycoproteins and human therapeutics, including kinases, viral antigens and antibodies. The company was founded by Terry E. Chase, Minh Q. Pham and William E. Bentley in 1998 and is headquartered in Savage, MD. | Health Technology |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |